​

Funding Round

Series A - Oxford Endovascular

Series A - Oxford Endovascular

Investment Firm

Overview

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Announced Date

May 20, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Parkwalk Advisors

Parkwalk Advisors

Parkwalk Advisors is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorNorcliffe Capital
Participant InvestorVulpes Investment Management Pte Ltd
Participant InvestorOxford Science Enterprises
Participant InvestorParkwalk Advisors
Participant InvestorUniversity of Oxford

Round Details and Background

Oxford Endovascular raised $10167678 on 2024-05-20 in Series A

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 14, 2020
Grant - Oxford Endovascular
1-461.8K
Jun 07, 2022
Non Equity Assistance - Oxford Endovascular
1-undefined
May 20, 2024
Series A - Oxford Endovascular
5-10.2M
Dec 16, 2015
Seed Round - Oxford Endovascular
1-3.0M

Recent Activity

There is no recent news or activity for this profile.